HYUNDAI BIOLAND Co.Ltd (052260) - Total Assets
Based on the latest financial reports, HYUNDAI BIOLAND Co.Ltd (052260) holds total assets worth ₩165.86 Billion KRW (≈ $112.40 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
HYUNDAI BIOLAND Co.Ltd - Total Assets Trend (2011–2024)
This chart illustrates how HYUNDAI BIOLAND Co.Ltd's total assets have evolved over time, based on quarterly financial data. Also see HYUNDAI BIOLAND Co.Ltd (052260) total market value for the company's overall valuation and market capitalisation.
HYUNDAI BIOLAND Co.Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
HYUNDAI BIOLAND Co.Ltd's total assets of ₩165.86 Billion consist of 55.0% current assets and 45.0% non-current assets. Review 052260 current and long-term liabilities to assess the company's total debt and financial obligations.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩21.01 Billion | 10.8% |
| Accounts Receivable | ₩13.02 Billion | 6.7% |
| Inventory | ₩57.40 Billion | 29.5% |
| Property, Plant & Equipment | ₩67.03 Billion | 34.4% |
| Intangible Assets | ₩2.11 Billion | 1.1% |
| Goodwill | ₩1.73 Billion | 0.9% |
Asset Composition Trend (2011–2024)
This chart illustrates how HYUNDAI BIOLAND Co.Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See today's stock price for HYUNDAI BIOLAND Co.Ltd for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: HYUNDAI BIOLAND Co.Ltd's current assets represent 55.0% of total assets in 2024, an increase from 0.0% in 2011.
- Cash Position: Cash and equivalents constituted 10.8% of total assets in 2024, up from 7.4% in 2011.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, unchanged from 1.0% in 2011.
- Asset Diversification: The largest asset category is property, plant & equipment at 34.4% of total assets.
HYUNDAI BIOLAND Co.Ltd Competitors by Total Assets
Key competitors of HYUNDAI BIOLAND Co.Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
NeoPharm CO. LTD
KQ:092730
|
Korea | ₩207.38 Billion |
|
Globon Co. Ltd
KQ:019660
|
Korea | ₩19.69 Billion |
|
Gentrogroup Co. Ltd.
KQ:083660
|
Korea | ₩50.42 Billion |
|
LG Energy Solution Ltd
KO:373220
|
Korea | ₩71.81 Trillion |
|
LIG Nex1 Co Ltd
KO:079550
|
Korea | ₩7.36 Trillion |
|
HYBE Co. Ltd
KO:352820
|
Korea | ₩5.66 Trillion |
|
Daeduck Electronics Co Ltd
KO:353200
|
Korea | ₩1.37 Trillion |
|
Robotis Co.Ltd
KQ:108490
|
Korea | ₩372.09 Billion |
HYUNDAI BIOLAND Co.Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.51 | 1.93 | 1.53 |
| Quick Ratio | 1.63 | 0.90 | 0.71 |
| Cash Ratio | 0.00 | 0.43 | 0.00 |
| Working Capital | ₩64.87 Billion | ₩43.24 Billion | ₩18.94 Billion |
HYUNDAI BIOLAND Co.Ltd - Advanced Valuation Insights
This section examines the relationship between HYUNDAI BIOLAND Co.Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.88 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 5.8% |
| Total Assets | ₩194.73 Billion |
| Market Capitalization | $40.97 Million USD |
Valuation Analysis
Below Book Valuation: The market values HYUNDAI BIOLAND Co.Ltd's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: HYUNDAI BIOLAND Co.Ltd's assets grew by 5.8% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for HYUNDAI BIOLAND Co.Ltd (2011–2024)
The table below shows the annual total assets of HYUNDAI BIOLAND Co.Ltd from 2011 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | ₩194.73 Billion ≈ $131.96 Million |
+5.79% |
| 2023-12-31 | ₩184.07 Billion ≈ $124.74 Million |
+4.53% |
| 2022-12-31 | ₩176.10 Billion ≈ $119.34 Million |
+1.94% |
| 2021-12-31 | ₩172.74 Billion ≈ $117.07 Million |
-7.95% |
| 2020-12-31 | ₩187.66 Billion ≈ $127.17 Million |
-10.23% |
| 2019-12-31 | ₩209.05 Billion ≈ $141.67 Million |
+8.23% |
| 2018-12-31 | ₩193.16 Billion ≈ $130.90 Million |
+9.52% |
| 2017-12-31 | ₩176.37 Billion ≈ $119.52 Million |
+5.19% |
| 2016-12-31 | ₩167.67 Billion ≈ $113.63 Million |
+9.33% |
| 2015-12-31 | ₩153.36 Billion ≈ $103.93 Million |
+7.13% |
| 2014-12-31 | ₩143.16 Billion ≈ $97.02 Million |
+0.44% |
| 2013-12-31 | ₩142.53 Billion ≈ $96.59 Million |
-3.08% |
| 2012-12-31 | ₩147.06 Billion ≈ $99.66 Million |
+14.13% |
| 2011-12-31 | ₩128.86 Billion ≈ $87.32 Million |
-- |
About HYUNDAI BIOLAND Co.Ltd
HYUNDAI BIOLAND Co.,Ltd manufactures and sells raw materials for cosmetics, nutraceuticals, and regenerative medicines. It offers anti-aging, moisturizing, whitening, skin protection, and other cosmetic ingredients; functional food ingredients and general food raw materials; and active pharmaceutical ingredients. The company was formerly known as SKbioland Co., Ltd. and changed its name to HYUNDA… Read more